Mesothelioma Cancer Resources Blog
- Iron Range Health Screenings Yield More Mesothelioma Cases
As University of Minnesota researchers continue to try to get to the cause of the high incidence of mesothelioma cases among the Iron Range, Minnesota taconite miners, they have found an additional 4 cases of mesothelioma. Mesothelioma is a rare form of cancer typically affecting the lining of the lungs. Primarily caused by exposure to …
Label: Mesothelioma
Posted on Wednesday, Mar 31, 2010 - Conference on Asbestos and Mesothelioma to be Held in May
Co-chaired by renowned physicians Samuel Hammar, MD, Director of Diagnostic Specialty Laboratories, Bremerton, WA and Victor L. Roggli, MD, Professor of Pathology, Duke University Medical Center, Durham, NC, the Conference on Asbestos and Mesothelioma brings together some of the world’s best known asbestos researchers, physicians, and scientists. Often called “asbestos cancer,” mesothelioma is highly aggressive …
Label: Mesothelioma
Posted on Tuesday, Mar 30, 2010 - Bionomics Phase II Clinical Trial to Provide Hope and Opportunity for Mesothelioma Sufferers
Bionomics, an Australian drug company focused on new treatments for cancer and serious disorders of the central nervous system, has announced they will initiate a phase II trial of BNC105 as second line chemotherapy for advanced malignant pleural mesothelioma (MPM). Bionomics has already commenced Phase II testing of the anti-cancer properties of BNC105 in renal …
Label: Research News
Posted on Monday, Mar 29, 2010 - Last Week to Nominate Your Mesothelioma Oncology Nurse
Cure magazine’s “Extraordinary Healer Award for Oncology Nursing” will be accepting nominations until April 5th. The nominations can be “from patients, survivors, caregivers, and peers describing the compassion, expertise, and helpfulness that a special oncology nurse has exhibited.” Cure will honor three nurse finalists, as well as the individuals who nominated them, with round-trip airfare …
Label: For Your Family
Posted on Friday, Mar 26, 2010 - Maintenance Chemotherapy Treatment with Alimta May Improve Survival Rate of Mesothelioma Patients
ast year the FDA gave approval for Alimta, a chemotherapy used in the treatment of non-small cell lung cancer and mesothelioma, to be used in maintenance treatment in patients with advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based first line chemotherapy. Mesothelioma is a cancer …
Label: Mesothelioma Treatment News
Posted on Thursday, Mar 25, 2010 - Study Tests the Effectiveness of Combination Chemotherapy for Post-Surgery Mesothelioma Treatment
A study led by Dr. David Sugarbaker, Chief of Thoracic Surgery at Brigham and Women’s Hospital and a mesothelioma specialist, is exploring whether Cisplatin can be used safely in combination with another anti-cancer drug, Gemcitabine to treat mesothelioma patients. Specifically the team is testing the effectiveness of using a combination of the chemotherapy drugs after …
Label: Research News
Posted on Wednesday, Mar 24, 2010 - Completion of Endostar Phase IV Trial Hopeful for Mesothelioma Treatment
Simcere Pharmaceutical Group, a Chinese manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar, announced this week the successful completion of Endostar Phase IV clinical trial. Since September 2005, Endostar has been approved to treat Non-Small-Cell Lung Cancer (NSCLC) in China. Endostar is a modified version of recombinant …
Label: Treatment News
Posted on Tuesday, Mar 23, 2010 - New York Attorney Applauds Mesothelioma Research Breakthrough
Attorney Joseph W. Belluck applauded news that an investigational vaccine created by researchers in the Netherlands may be able to use matter from mesothelioma tumors to provoke the immune system into generating antibodies to fight the mesothelioma cells. This vaccine has proven to be safe in studies to date. Belluck, of Belluck & Fox, a …
Label: Mesothelioma Research News
Posted on Monday, Mar 22, 2010 - Proposal to Limit Mesothelioma-Causing Asbestos Lawsuits Rejected in Virginia
Virginia senators voted 13-2 to defeat the bill that would limit asbestos-related liability for Philadelphia-based Crown Cork & Seal. The company, a beverage packaging firm that invented the bottle cap, has faced hundreds of lawsuits for asbestos-related illnesses, such as mesothelioma, related to Mundet, a business Crown Cork purchased in 1963. The special bill would …
Label: Mesothelioma
Posted on Friday, Mar 19, 2010 - Type of Pleural Effusion Important for Mesothelioma Diagnosis
Pleural effusions are found in 95% of all pleural mesothelioma cases. When a patient presents to a doctor with pleural effusion, however, there are many other diseases which could cause the fluid buildup. There are multiple medical tests that should be conducted by the physician to determine the cause, but when exudative pleural effusion is …
Label: Featured Story
Posted on Thursday, Mar 18, 2010



